BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4617092)

  • 21. Amantadine hydrochloride in the treatment of Parkinson's disease.
    Nagaswami S; Ranjini R
    J Kans Med Soc; 1971 Nov; 72(11):465-8. PubMed ID: 5120698
    [No Abstract]   [Full Text] [Related]  

  • 22. L-dopa and amantadine in the therapy of parkinsonism.
    Weeth JB; Shealy CN; Mercier DA
    Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effectiveness of a combination therapy in the Parkinson syndrome by amantadine hydrochloride and anticholinergic agents].
    Gospavić J; Vidaković Z
    Srp Arh Celok Lek; 1974 Jun; 102(6):447-57. PubMed ID: 4450143
    [No Abstract]   [Full Text] [Related]  

  • 24. Controlled trial of amantadine hydrochloride in Parkinson's disease.
    Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF
    N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146
    [No Abstract]   [Full Text] [Related]  

  • 25. [Adamantylamine sulfate--a drug for treatment of Parkinson's disease with a new working principle].
    Fünfgeld EW
    Med Klin; 1970 Sep; 65(39):1703-6. PubMed ID: 5474341
    [No Abstract]   [Full Text] [Related]  

  • 26. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
    [No Abstract]   [Full Text] [Related]  

  • 27. [Amantadine in the treatment of Parkinson's disease].
    Giombini S; Solero CL; Bazzan A; Ferrari P; Robotti E
    Fracastoro; 1970; 63(6):869-81. PubMed ID: 5519639
    [No Abstract]   [Full Text] [Related]  

  • 28. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
    Ambrosetto C; Martinelli P
    Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069
    [No Abstract]   [Full Text] [Related]  

  • 30. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial.
    Appleton DB; Eadie MJ; Sutherland JM
    Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572
    [No Abstract]   [Full Text] [Related]  

  • 31. Trial of amantadine in Parkinson's disease.
    Campbell AM; Williams MJ
    Br J Clin Pract; 1972 Jan; 26(1):19-22. PubMed ID: 4554563
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects induced by the treatment with amantadine on habituation of trigemino-facial reflexes in Parkinsonian patients].
    Messina C; Tomasello F
    Riv Neurol; 1972; 42(2):202-8. PubMed ID: 4341955
    [No Abstract]   [Full Text] [Related]  

  • 33. [Combined use of metamizil and midantan in vascular parkinsonism].
    Kamenetskiĭ VK
    Klin Med (Mosk); 1979 Sep; 57(9):59-62. PubMed ID: 491516
    [No Abstract]   [Full Text] [Related]  

  • 34. [Preliminary results of the use of amantadine in parkinsonian syndromes].
    Montanari M; Monaco V; Robotti CA
    Minerva Med; 1971 Oct; 62(82):3955-7. PubMed ID: 5125050
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current drug treatment of parkinsonism].
    Kistenev BA; Kadykov AS; Pivovarova VM
    Sov Med; 1976 Nov; (11):57-61. PubMed ID: 1006394
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of amantadine on some psychomotor performances in Parkinsonism. A double blind study.
    Laitinen LV; Vilkki J
    Ann Clin Res; 1971 Aug; 3(4):207-11. PubMed ID: 4937341
    [No Abstract]   [Full Text] [Related]  

  • 37. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
    Merrick EM; Schmitt PP
    Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism].
    Man'kovskii NB; Vainshtok AB; Oleinik LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407
    [No Abstract]   [Full Text] [Related]  

  • 39. [Action of amantadine on parkinsonian tremor].
    Agnoli A; Casacchia M; Ruggieri S; Volante F; Accornero N
    Minerva Med; 1971 Oct; 62(82):3990-3. PubMed ID: 5125061
    [No Abstract]   [Full Text] [Related]  

  • 40. Amantadine in Parkinsonism. An extended prospective trial.
    Rao NS; Pearce J
    Practitioner; 1971 Feb; 206(232):241-5. PubMed ID: 4928964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.